NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 100 filers reported holding NUVALENT INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $71,546,192 | -2.3% | 1,556,367 | -10.4% | 0.01% | 0.0% |
Q2 2023 | $73,227,656 | +48.8% | 1,736,487 | -8.0% | 0.01% | +40.0% |
Q1 2023 | $49,223,377 | +15.1% | 1,886,676 | +31.3% | 0.01% | +11.1% |
Q4 2022 | $42,775,665 | +131.6% | 1,436,389 | +51.2% | 0.01% | +125.0% |
Q3 2022 | $18,468,000 | +35.4% | 949,967 | -5.5% | 0.00% | +33.3% |
Q2 2022 | $13,637,000 | -2.4% | 1,005,706 | 0.0% | 0.00% | +50.0% |
Q1 2022 | $13,969,000 | -27.2% | 1,005,706 | -0.8% | 0.00% | -33.3% |
Q4 2021 | $19,189,000 | -16.7% | 1,013,473 | -3.4% | 0.00% | -25.0% |
Q3 2021 | $23,024,000 | – | 1,049,571 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,788,981 | $83,055,854 | 13.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $595,332,695 | 12.32% |
Bain Capital Life Sciences Investors, LLC | 3,577,267 | $106,531 | 11.90% |
COMMODORE CAPITAL LP | 913,621 | $27,208 | 4.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 302,963 | $9,022,238 | 2.58% |
Boxer Capital, LLC | 1,210,192 | $36,039,518 | 1.90% |
Perceptive Advisors | 2,255,007 | $67,154,108 | 1.89% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,673,214 | $49,828,313 | 0.74% |
Avoro Capital Advisors LLC | 1,555,555 | $46,324,428 | 0.69% |
AlphaCentric Advisors LLC | 15,500 | $461,590 | 0.46% |